Editorial Policies

 

FOCUS AND SCOPE

Folia Medica Indonesiana publishes articles in whole aspects of medical sciences, including pre-clinical medicines such as biomedicine, anatomy, histology, biochemistry, physiology, microbiology, parasitology, pathology, and pharmacology; clinical medicines, such as obstetrics and gynecology, pediatrics, internal medicine, ophthalmology, surgery, neurology, otolaryngology, cardiology, anaesthesiology; as well as rehabilitative medicine, public health, and preventive medicine. The articles are presented as original articles, case reports, and literature reviews.

 

SECTION POLICIES

ORIGINAL RESEARCH REPORT

Checked Open Submissions Checked Indexed Checked Peer-Reviewed

CASE REPORTS/ CASE STUDY

Checked Open Submissions Checked Indexed Checked Peer-Reviewed

REVIEW ARTICLES

Checked Open Submissions Checked Indexed Checked Peer-Reviewed
 

 

PUBLICATION FREQUENCY

Folia Medica Indonesiana is published four times a year in March, June, September, and December. Each issue publishes fifteen articles or sixty articles in each volume year.

 

OPEN ACCESS POLICY

Folia Medica Indonesiana provides open access to its content and is licensed under Creative Commons attribution CC-BY-NC-SA (https://creativecommons.org/licenses/by-nc-sa/4.0/). This license allows users to copy and redistribute the material in any medium or format, remix, transform, and build upon the material. The licensor cannot revoke these freedoms as long as the users follow the license terms. Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses users or their use. Users may not use the material for commercial purposes. If users remix, transform or build upon the material, they must distribute their contributions under the same license as the original. Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. Users do not have to comply with the license for elements of the material in the public domain or where their use is permitted by an applicable exception or limitation. No warranties are given. The license may not give users all of the permissions necessary for their intended use. For example, other rights such as publicity, privacy, or moral rights may limit how users use the material.

 

ARCHIVING

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

REFERENCE MANAGER

Every article submitted to Folia Medica Indonesiana shall use reference management software e.g. EndNote® or Mendeley.

 

PUBLICATION ETHICS AND MALPRACTICE STATEMENT

Folia Medica Indonesiana is a journal that aims to publish original research papers, review articles, and case studies on basic and clinical medicine presented as original research reports, review articles, and case reports. This journal applies ethical rules of conduct established by all parties involved in the publication of manuscripts in this journal, including the authors, the editor-in-chief, the editorial board, and the peer-reviewers. This statement is adopted under Committee on Publication Ethics (COPE).

 

Duties of Authors

  1. Submission

Authors must submit all elements of their manuscripts online at http://e-journal.unair.ac.id/index.php/FMI/about/submissions#onlineSubmissions. Hard-copy submissions will NOT be considered or returned. A completed CTA & Authors' Declaration form, which can be downloaded from this website, and signed by all authors must accompany all submissions. Authors are also encouraged to apply acceptable checklists in this journal (i.e., CASP, COREQ, CHEERS, CROSS, ENTREQ, GRADE-CERQual, GRIPP2, PRISMA (2020), PRISMA-ScR, SRQR, STROBE, TIDieR-PHP, TRIPOD). 

  1. Human and Animal Subjects

The research being reported should have been conducted ethically and responsibly and should comply with all relevant legislation. For manuscripts reporting medical studies involving human participants, authors must provide a statement identifying the ethics committee that approved the study, and the study conforms to recognized standards (for example Declaration of Helsinki). Research involving animals should be conducted with the same rigor as research on humans. Authors should implement the 3Rs principles (Replacement, Reduction, Refinement). Authors must describe the details journals regarding study design and statistical analysis, experimental procedures, experimental animals, housing, and husbandry. Authors must inform that ethical and legal approval was obtained before the start of the study, and state the name of the body approving. Authors should also state whether experiments were performed by relevant institutional and national guidelines and regulations.

  1. Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review. They should be prepared to provide such data within a reasonable time.

  1. Reporting Manuscript’s Standards

Authors must present an accurate account of the original article (research, review, or case report) performed as well as an objective discussion of its significance. Authors should present their results, honestly, and without fabrication, falsification, or inappropriate data manipulation. Authors should strive to describe their methods clearly and unambiguously so that their findings can be confirmed by others. Fraudulent or knowingly inaccurate statements constitute unethical behavior and will be unacceptable.

  1. Originality and Plagiarism

Authors must ensure that they have written manuscripts that adhere to publication requirements that the submitted work is original, is not plagiarized, and has not been published elsewhere. The manuscript should not be submitted concurrently to more than one publication unless the editors have agreed to co-publication. Relevant previous work and publications, both by other researchers and the authors’ own, should be properly acknowledged and referenced. The primary literature should be cited where possible. Original wording taken directly from publications by other researchers should appear in quotation marks with the appropriate citations.

  1. Duplicate and Redundant Publications

Authors must avoid duplicate publication, which is reproducing verbatim content from their other publications. Authors should not submit and are also expected will not to publish redundant manuscripts or manuscripts describing the same research in more than one journal. Multiple publications arising from a single research project should be identified as such and the primary publication should be referenced

  1. Acknowledgment of Sources

All sources of data used in the research and cite publications that have been influential in determining the nature of the reported work should be properly identified. Authors must present a proper acknowledgment of the work of others.

  1. Authorship of the Manuscript

The authorship of research publications should accurately reflect individuals’ contributions to the work and its reporting. Authors ensure that all the authors have seen and agreed to the submitted version of the manuscript and their inclusion of names as co-authors. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. Others who have made significant contributions must be listed as co-authors. In cases where major contributors are listed as authors while those who made less substantial, or purely technical, contributions to the research or the publication are listed in an acknowledgment section.

  1. Disclosure and Conflicts of Interest

Funding sources and relevant conflicts of interest should be disclosed. Authors have to disclose any financial or other substantive conflicts of interest that might be supposed to influence the results or interpretation of their manuscripts.

  1. Fundamental Errors in Published Works

It is the author's responsibility to contact the journal's editors or publishers as soon as they uncover substantial errors or inaccuracies in their own published work, and to work with them to either rectify the manuscript in the form of erratum or retract the paper. If a third party informs the editor or publisher that a published work has a serious error or inaccuracy, the authors must promptly fix or retract the publication, or give evidence to the journal editors that the paper is correct.

  1. Peer Review

Authors must take a part in the peer review process and cooperate completely with editors by providing raw data, clarificating, and and verification of ethics approval, patient consents, and copyright permissions as soon as possible. When a first decision of "revision necessary" is made, authors should reply to the reviewers' remarks in a methodological, point-by-point, and timely manner. amending and resubmitting their manuscript to the journal within the provided deadline.

 

Duties of Editor

  1. Publication Decisions

Editors are accountable and should take responsibility for everything they publish. Editors should apply consistent standards in their processes so that have procedures and policies in place to ensure the quality of the material they publish and maintain the integrity of the published record. Based on the review report of the editorial board, the editor can accept, reject, or request modifications to the manuscript. Editors should aim to ensure timely peer review and publication and should avoid unnecessary delays. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement, and plagiarism that encourage maximum transparency and complete, honest reporting.

  1. Review of Manuscripts

The editor must ensure that each manuscript is initially evaluated by the editor for originality. Editors should critically assess the ethical conduct of studies in humans and animals. The editor should organize and use peer review fairly and wisely. Editors should explain their peer review processes in the information for authors and also indicate which parts of the journal are peer-reviewed. Editors should use appropriate peer reviewers for papers that are considered for publication by selecting people with sufficient expertise and avoiding those with conflicts of interest.

  1. Fair Play

Editors should make fair and unbiased decisions independent of commercial considerations and ensure a fair and appropriate peer-review process. The editor must ensure that each manuscript received by the journal is reviewed for its intellectual content without regard to the sex, gender, race, religion, citizenship, etc. of the authors. Editors are in a powerful position by making decisions on publications, which makes it very important that this process is as fair and unbiased as possible.

  1. Confidentiality 

Editors should ensure confidential handling of manuscripts, with no details being disclosed to anyone except the peer reviewers without the author's permission. If discussions between an author, editor, and peer reviewer have taken place in confidence, they should remain in confidence unless explicit consent has been given by all parties, or unless there are exceptional circumstances (eg, when they might help substantiate claims of intellectual property theft during peer review).

  1. Disclosure and Conflicts of Interest

Editors should guard the integrity of the published record by issuing corrections and retractions when needed and pursuing suspected or alleged research and publication misconduct. The editor of the Journal will not use unpublished materials disclosed in a submitted manuscript for his research without the written consent of the author. And also, editors should not be involved in decisions about papers in which they have a conflict of interest.

 

Duties of Reviewers

Manuscripts submitted for publication in Folia Medica Indonesiana journals are subjected to double-blind peer-review. Double-blind reviewing maintains the identity of the authors as well as the reviewers, not disclosing their names to each other. The anonymity of authors and reviewers ensures an objective and unbiased assessment of the manuscript.

  1. Contribution to Editorial Decisions

Peer review assists the editor in making editorial decisions and the editorial communications with the author may also assist the author in improving the paper.

  1. Confidentiality

Information regarding manuscripts submitted by authors should be kept confidential and treated as privileged information. They must not be shown to or discussed with others except as authorized by the editor.

  1. Standards of Objectivity 

Review of submitted manuscripts must be done objectively and the reviewers should express their views clearly with supporting arguments. The results reported in the manuscript must be original and authentic work of the authors. They should be devoid of any plagiarism and the material should not have been published earlier. Experiments and other analyses should meet the recognized technical standards and must be described systematically. The manuscript must provide a statement identifying the ethics committee that approved the study, and the study conforms to recognized standards. The research presented in a manuscript should facilitate reaching accurate conclusions from the statistics. Methods and experiments as well as reagents should be documented in detail. Authors should present and interpret the results and conclusions appropriately and comprehensively, clearly explaining the results and outcomes of their study. Incomplete interpretation of results may result in rejection of the manuscript. Furthermore, the manuscript should be written in English in a clear, direct, and active style, free from grammatical errors and other linguistic inconsistencies. All pages should be numbered sequentially, facilitating the reviewing and editing of the manuscript (see duties of Authors).

  1. Disclosure and Conflict of Interest

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.  Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

  1. Promptness

The reviewers should respond in a reasonable time frame. If they cannot return a review within the proposed time, they should inform the journal promptly and explain they require an extension. If a reviewer feels him/her can't complete the review of the manuscript within the stipulated time then this information must be communicated to the editor so that the manuscript can be sent to another reviewer.

  1. Acknowledgment of Sources

Reviewers should identify relevant published work that the authors have not cited. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

 

PEER REVIEW PROCESS

Any manuscript submitted to this journal is first checked by an editor for evaluating whether the manuscript is suitable for the journal's aim and scope, the completion of all elements of the manuscript, such as the IMRAD, the clearness of tables and figures, proper referencing, and also possible plagiarism. The author will be notified if flaws are found in this step within three days after submission. Once there are no flaws, the author is eligible to receive a Letter of Submission, and the manuscript is further submitted to reviewers. A manuscript will be reviewed by at least 2 independent reviewers. They are appointed from other institutions, either national or international. The reviewing process is double-blind peer-reviewed, in which the author does not know who reviews his/her manuscript, while, as the manuscript, itself is sent anonymously, the reviewers do not know who the authors are. Reviewers' comments are sent anonymously to the author for revision. The revised manuscript will be discussed in a regular meeting of the editorial board where the final decision regarding the publication eligibility of the manuscript is decided. Once a revised manuscript is regarded as eligible for publication, a Letter of Acceptance is issued to the corresponding author. The whole process is generally completed within 6-10 weeks.

 

ARTICLE PROCESSING CHARGE

The article processing charge for publication in Folia Medica Indonesiana is IDR 1.5 Million. Payment is due after the manuscript is accepted for publication in the journal. The journal does not require any submission charge.

Waiver Policy

We will consider all requests for discretionary APC waivers by researchers who are not eligible for the above. Please state your request for a discretionary waiver before submitting your manuscript by email to the APC team at fmi@journal.unair.ac.id (Achmad Naufal Irsyadi).

Please include supporting evidence for why a waiver would be necessary for your circumstances. Your request should be details of:

  1. The affiliation and country of residence of all authors;
  2. Details of where the research was conducted; and
  3. Confirmation of all research grant funding received.
If you have already accepted a discounted price offered to you at the time of submission, please be aware that this is the maximum discount and we are unable to help you further.
 
Authors who receive the support of, or are employed by, a commercial organization (e.g., a Pharmaceutical company) will not be liable to receive this discounted price. They will be asked to pay the full advertised price in effect at the time of submission.
 
Discounts may not be combined and where multiple discounts are available the one most favorable to the authors will apply.
 
Discounts can be determined by journal managers only if the authors have already submitted their waiver request through fmi@journal.unair.ac.id.

The waiver request form can be downloaded here.

 

PLAGIARISM CHECK

Folia Medica Indonesiana does tolerate any type of plagiarism. The editors of Folia Medica Indonesiana will screen all submitted manuscripts for plagiarism using the Turnitin plagiarism checker. A similarity of more than 20% is not acceptable. Any manuscript that does not meet this requirement at the first screening should be revised by its authors before being re-submitted accordingly.

 

EXTERNAL LINKS

Folia Medica Indonesiana is now under cooperation with Unit Konsorsium Jurnal dan FMI (UKJF), Faculty of Medicine, Universitas Airlangga. The information can be accessed through an external link https://ukjf.fk.unair.ac.id/.

 

REPOSITORY POLICY

Folia Medica Indonesiana allows authors to deposit versions of their work. All published articles are deposited in the Portal Garuda repository.

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.